Inventor

NUSSENZWEIG MICHEL

US27 patents

⚠️ This page may combine multiple inventors who share the name “NUSSENZWEIG MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NUSSENZWEIG MICHEL

UNIV ROCKEFELLER

Broadly-neutralizing anti-HIV antibodies

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Neutralizing anti-SARS-CoV-2 antibodies

HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants

Combination of broadly neutralizing HIV antibodies and viral inducers

Neutralizing anti-SARS-CoV-2 antibodies and methods of use thereof

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Neutralizing anti-SARS-CoV-2 antibodies

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Broadly neutralizing antibodies that target HIV ENV V3 N-glycans

Broadly-neutralizing anti-HIV antibodies

Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunits

Broadly neutralizing anti-HIV-1 antibodies and methods of use thereof

Broadly neutralizing anti-HIV-1 antibodies and methods of use thereof

Broadly neutralizing anti-HIV-1 antibodies and methods of use thereof

Combination of broadly neutralizing HIV antibodies and viral inducers

HIV vaccine immunogens

Neutralizing antibodies that bind to the zika virus domain III envelope region

Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits

Anti-HIV antibody 10-1074 variants

CALIFORNIA INST OF TECHN

Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth

Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120

The Rockefeller Universtiy

Broadly-neutralizing anti-HIV antibodies

Broadly neutralizing antibody directed against HIV-1 GP140

SCHEID JOHANNES

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

DISKIN RON

Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120